title: In vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrant-associated carcinogenesis.
abstract: An important event in the development of cervical squamous cell carcinoma (SCC) is deregulated expression of high-risk human papillomavirus (HR-HPV) oncogenes, most commonly related to viral integration into host DNA. Mechanisms of development of the approximately 15% of SCCs that contain extrachromosomal (episomal) HR-HPV are poorly understood due to limited longitudinal data. We therefore used the W12 model to study mechanisms of cervical carcinogenesis associated with episomal HPV16. In vitro progression of W12 normally occurs through selection of cells containing integrated HPV16. However, in one long-term culture, keratinocytes developed a selective growth advantage and invasive phenotype while retaining HPV16 episomes at increased copy number in the absence of transcriptionally active integrants. Longitudinal investigations revealed similarities between the episome- and integrant-associated routes of neoplastic progression. Most notable were dynamic changes in viral early gene expression in episome-retaining cells, consistent with continually changing selective pressures. An early increase in viral transcription preceded elevated episome copy number and was followed by a reduction to near baseline after the development of invasiveness. Episomal transcriptional deregulation did not require selection of a specific sequence variant of the HPV16 upstream regulatory region, although increased levels of acetylated histone H4 around the late promoter implicated a role for altered chromatin structure. Interestingly, invasive episome-retaining cells showed high levels of HPV16 E2/E6 proteins (despite decreased transcript levels) and reduced expression of IFN-stimulated genes, adaptations that support viral persistence and cell survival. Our findings suggest a unified working model for events important in cervical neoplastic progression regardless of HR-HPV physical state.
authors.affiliation: Medical Research Council Cancer Cell Unit, University of Cambridge, Cambridge, United Kingdom.
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Gray
authors.forename: Mark R
authors.initials: MR
authors.lastname: Pett
authors.forename: Dawn
authors.initials: D
authors.lastname: Ward
authors.forename: David M
authors.initials: DM
authors.lastname: Winder
authors.forename: Margaret A
authors.initials: MA
authors.lastname: Stanley
authors.forename: Ian
authors.initials: I
authors.lastname: Roberts
authors.forename: Cinzia G
authors.initials: CG
authors.lastname: Scarpini
authors.forename: Nicholas
authors.initials: N
authors.lastname: Coleman
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000235:genetics / Q000473:pathology / Q000821:virology*; D002478:Cells, Cultured; D047369:Chromatin Immunoprecipitation; D019175:DNA Methylation; D004279:DNA, Viral / Q000235:genetics / Q000378:metabolism; D005260:Female; D018628:Gene Dosage; D052162:Human papillomavirus 16 / Q000502:physiology*; D006801:Humans; D015603:Keratinocytes / Q000473:pathology* / Q000821:virology; D030361:Papillomavirus Infections / Q000235:genetics / Q000473:pathology / Q000821:virology*; D010957:Plasmids / Q000235:genetics* / Q000378:metabolism; D002583:Uterine Cervical Neoplasms / Q000235:genetics / Q000473:pathology / Q000821:virology*; D016662:Virus Integration
chemical_list: D004279:DNA, Viral